Table 1.
Baseline characteristics of the study population.
| Subject | Controls (n = 98) |
PVCs (n = 94) |
p Value |
|---|---|---|---|
| Age (yrs) | 50.84 ± 9.41 | 49.83 ±13.63 | 0.551 |
| Male (n,%) | 55 (56.1) | 47 (50.0) | 0.395 |
| Height (cm) | 166.54 ± 7.58 | 165.97 ± 6.89 | 0.590 |
| Weight (kg) | 69.39 ± 13.38 | 65.92 ± 10.95 | 0.052 |
| Body mass index (kg/m2) | 24.89 ± 3.65 | 23.87 ± 3.36 | 0.050 |
| Smoking (n,%) | 15 (15.3) | 11 (11.8) | 0.484 |
| CAD (n,%) | 18 (18.1) | 16 (17.0) | 0.156 |
| ACS (n,%) | 10 (10.2) | 9 (9.6) | 0.892 |
| Number of lesional coronary artery | 0.771 | ||
| 1-vessel CAD (n,%) | 6 (6.1) | 8 (8.5) | |
| 2-vessel CAD (n,%) | 4 (4.1) | 3 (3.1) | |
| 3-vessel CAD (n,%) | 8 (8.2) | 5 (5.3) | |
| Gensini score | 16.77 ± 11.45 | 19.20 ± 17.01 | 0.672 |
| Hypertension (n,%) | 33 (33.7) | 47 (50.0) | 0.071 |
| Hyperlipidemia (n,%) | 23 (23.5) | 24 (25.5) | 0.997 |
| Diabetes (n,%) | 12 (12.2) | 14 (14.9) | 0.758 |
| Medication use | |||
| Beta-blocker (n,%) | 44 (44.9) | 37 (37.8) | 0.204 |
| Calcium channel blocker (n,%) | 19 (19.4) | 28 (28.6) | 0.178 |
| Laboratories | |||
| NT-proBNP (pg/mL) | 35.5 (49.5) | 62.1 (83.0) | 0.044 † |
| cTnI (ng/mL) | 5.32 ± 14.30 | 4.24 ± 6.81 | 0.509 |
| eGFR (mL/min/1.73 m²) | 91.86 ± 12.83 | 89.34 ± 20.97 | 0.532 |
† Comparison between the two groups conducted using the Mann–Whitney U test. Abbreviations: PVC, premature ventricular complex; CAD, coronary artery disease; ACS, acute coronary syndrome; NT-proBNP, N-terminal pro-brain natriuretic peptide.